| Date Filed | Type | Description |
| 08/03/2023 |
4
| DArecca James (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,295 shares
@ $0 |
|
| 08/03/2023 |
3
| DArecca James (Director) has filed a Form 3 on Prestige Consumer Healthcare Inc. |
| 05/17/2023 |
4
| DArecca James (EVP, CFO) has filed a Form 4 on HAEMONETICS CORP|
Txns:
| Granted 4,205 shares
@ $0
Paid exercise price by delivering 349 shares
@ $89.21, valued at
$31.1k
Granted 9,502 options to buy
@ $89.16, valued at
$847.2k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
3
| DArecca James (EVP, CFO) has filed a Form 3 on HAEMONETICS CORP |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/19/2020 |
4
| DArecca James (CFO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 151,500 rights
@ $0
Granted 651,500 restricted stock units
@ $0 |
|
| 06/04/2020 |
3
| DArecca James (CFO) has filed a Form 3 on TherapeuticsMD, Inc. |
| 05/11/2020 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 3,511 shares
@ $0
Disposed/sold 6,324 restricted stock units
@ $0
Disposed/sold 1,169 options
@ $296.14, valued at
$346.2k
Disposed/sold 4,957 options
@ $224, valued at
$1.1M
Disposed/sold 3,534 rights
@ $0 |
|
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2019 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 359 shares
@ $143, valued at
$51.3k
Paid exercise price by delivering 113 shares
@ $145.06, valued at
$16.4k
|
|
| 03/08/2019 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Granted 2,036 shares
@ $137.51, valued at
$280k
|
|
| 03/06/2019 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 114 shares
@ $139.12, valued at
$15.9k
|
|
| 03/06/2019 |
4/A
| DArecca James (Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,826 shares
@ $153.22, valued at
$279.8k
|
|
| 01/03/2019 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 147 shares
@ $133.66, valued at
$19.6k
|
|
| 03/09/2018 |
4
| DArecca James (Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 79 shares
@ $153.5, valued at
$12.1k
|
|
| 03/08/2018 |
4
| DArecca James (Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 93 shares
@ $153.22, valued at
$14.2k
Granted 1,696 shares
@ $153.22, valued at
$259.9k
|
|
| 03/06/2018 |
4
| DArecca James (Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 76 shares
@ $144.02, valued at
$10.9k
Paid exercise price by delivering 70 shares
@ $148.73, valued at
$10.4k
|
|
| 01/02/2018 |
4
| DArecca James (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 100 shares
@ $163.58, valued at
$16.4k
|
|
| 10/30/2017 |
4
| DArecca James (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Allergan plc|
Txns:
| Exercised 799 options to buy
@ $0 |
|
| 03/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2013 |
3
| DArecca James (VP, CHIEF ACCOUNTING OFFICER) has filed a Form 3 on Actavis plc |
| 08/09/2013 |
3
| DArecca James (Chief Accounting Officer) has filed a Form 3 on Actavis, Inc. |